Physiological parameter values for physiologically based pharmacokinetic models

被引:1108
作者
Brown, RP
Delp, MD
Lindstedt, SL
Rhomberg, LR
Beliles, RP
机构
[1] US EPA, NATL CTR ENVIRONM ASSESSMENT 8623, WASHINGTON, DC 20460 USA
[2] INT LIFE SCI INST, RISK SCI INST, WASHINGTON, DC USA
[3] TEXAS A&M UNIV, DEPT HLTH & KINESIOL, COLLEGE STN, TX USA
[4] NO ARIZONA UNIV, DEPT BIOL SCI, FLAGSTAFF, AZ 86011 USA
[5] HARVARD UNIV, SCH PUBL HLTH, HARVARD CTR RISK ANAL, BOSTON, MA 02115 USA
关键词
biological models; pharmacokinetics; physiological parameters;
D O I
10.1177/074823379701300401
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
[No abstract available]
引用
收藏
页码:407 / 484
页数:78
相关论文
共 239 条
  • [41] MEASUREMENT OF NORMAL PORTAL VENOUS-BLOOD FLOW BY DOPPLER ULTRASOUND
    BROWN, HS
    HALLIWELL, M
    QAMAR, M
    READ, AE
    EVANS, JM
    WELLS, PNT
    [J]. GUT, 1989, 30 (04) : 503 - 509
  • [42] HUMAN ADIPOSE-TISSUE BLOOD-FLOW DURING PROLONGED EXERCISE II
    BULOW, J
    MADSEN, J
    [J]. PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY, 1978, 376 (01): : 41 - 45
  • [43] HISTORY, SURVIVAL, AND GROWTH-PATTERNS OF B6C3F1 MICE AND F344 RATS IN THE NATIONAL CANCER INSTITUTE CARCINOGENESIS TESTING PROGRAM
    CAMERON, TP
    HICKMAN, RL
    KORNREICH, MR
    TARONE, RE
    [J]. FUNDAMENTAL AND APPLIED TOXICOLOGY, 1985, 5 (03): : 526 - 538
  • [44] ETHANOL-INDUCED INCREASE IN PORTAL BLOOD-FLOW - ROLE OF ACETATE AND A1-ADENOSINE AND A2-ADENOSINE RECEPTORS
    CARMICHAEL, FJ
    SALDIVIA, V
    VARGHESE, GA
    ISRAEL, Y
    ORREGO, H
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY, 1988, 255 (04): : G417 - G423
  • [45] SPLANCHNIC BLOOD-FLOW CHANGES IN THE PRESENCE OF HEPATIC TUMOR - EVIDENCE OF A HUMORAL MEDIATOR
    CARTER, R
    ANDERSON, JH
    COOKE, TG
    BAXTER, JN
    ANGERSON, WJ
    [J]. BRITISH JOURNAL OF CANCER, 1994, 69 (06) : 1025 - 1026
  • [46] EFFECTS OF CLENBUTEROL ON SKELETAL-MUSCLE MASS, BODY-COMPOSITION, AND RECOVERY FROM SURGICAL STRESS IN SENESCENT RATS
    CARTER, WJ
    DANG, AQ
    FAAS, FH
    LYNCH, ME
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 1991, 40 (08): : 855 - 860
  • [47] CASTER WO, 1956, P SOC EXP BIOL MED, V91, P122, DOI 10.3181/00379727-91-22186
  • [48] CLARYS JP, 1984, HUM BIOL, V56, P459
  • [49] INCORPORATION OF PHARMACOKINETICS IN NONCANCER RISK ASSESSMENT - EXAMPLE WITH CHLOROPENTAFLUOROBENZENE
    CLEWELL, HJ
    JARNOT, BM
    [J]. RISK ANALYSIS, 1994, 14 (03) : 265 - 276
  • [50] CLEWELL HJ, 1994, COMMUNICATION